Menu

ORI: Researcher Faked Dozens of Experiments

A former scientist at the University of Michigan and the University of Chicago made up more than 70 experiments on heart cells, according to the Office of Research Integrity.

May 25, 2016
Jef Akst

WIKIMEDIA, TIMVICKERS“All told, [Ricky] Malhotra claimed to have conducted 74 experiments that never happened, and falsified well over 100 Western blots,” Retraction Watch reported today (May 25). The former University of Michigan and University of Chicago researcher admitted to the misconduct, which over the course of six years involved three National Institutes of Health (NIH) grant applications and a 2010 manuscript published in the Journal of Biological Chemistry, according to a case summary published this week (May 24) by the Office of Research Integrity (ORI). The agency noted that Malhotra has agreed to retract the JBC paper.

According to his LinkedIn profile, Malhotra worked at an Ann Arbor, Michigan–based  microscopy company called PicoCal and is now serving as cardiovascular and metabolic consultant in the greater Boston area. He told the ORI that he does not plan to apply for any US Public Health Service funding. If he should do so in the next five years, his work will be supervised and he will be required to provide biannual reports to verify the legitimacy of his research, according to the ORI summary.

February 2019

Big Storms Brewing

Can forests weather more major hurricanes?

Marketplace

Sponsored Product Updates

Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today showcases new automation features of its ZE5 Cell Analyzer during the Society for Laboratory Automation and Screening 2019 International Conference and Exhibition (SLAS) in Washington, D.C., February 2–6. These capabilities enable the ZE5 to be used for high-throughput flow cytometry in biomarker discovery and phenotypic screening.
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Researchers to benefit from an innovative software-connected pipetting system, bringing improved reproducibility and traceability of experiments to life-science laboratories.
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Incorporated (NYSE: GLW) will showcase advanced 3D cell culture technologies and workflow solutions for spheroids, organoids, tissue models, and applications including ADME/toxicology at the Society for Laboratory Automation and Screening (SLAS) conference, Feb. 2-6 in Washington, D.C.
Corning Introduces New 1536-well Spheroid Microplate
Corning Introduces New 1536-well Spheroid Microplate
High-throughput spheroid microplate benefits cancer research, drug screening